Scinai Immunotherapeutics (SCNI) Interest & Investment Income (2023 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Interest & Investment Income came in at $13.4 million in Q3 2024, up 356.75% year-on-year from $2.9 million in Q4 2023, and up 356.75% quarter-over-quarter from -$5.2 million in Q3 2023.
Scinai Immunotherapeutics (SCNI) Interest & Investment Income (2023 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Interest & Investment Income across 2 years of filings, most recently posting $13.4 million for Q3 2024.
- Interest & Investment Income for Q3 2024 came in at $13.4 million, up 356.75% year-over-year; the trailing twelve-month figure through Sep 2024 was $13.4 million (up 356.75% YoY), and the FY2023 annual result was $9000.0, down 99.83% from the prior year.
- Interest & Investment Income came in at $13.4 million for Q3 2024 at Scinai Immunotherapeutics, up from -$5.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $13.4 million in Q3 2024 to a low of -$5.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 13.37 Mn |
| Sep 30, 2023 | -5.21 Mn |